BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 17306351)

  • 1. Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma.
    Manavi M; Hudelist G; Fink-Retter A; Gschwandtler-Kaulich D; Pischinger K; Czerwenka K
    Gynecol Oncol; 2007 May; 105(2):418-26. PubMed ID: 17306351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome profiling of cancer and normal tissues from cervical squamous cancer patients by deep sequencing.
    Lin W; Feng M; Li X; Zhong P; Guo A; Chen G; Xu Q; Ye Y
    Mol Med Rep; 2017 Aug; 16(2):2075-2088. PubMed ID: 28656315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction.
    Zhao M; Huang W; Zou S; Shen Q; Zhu X
    Int J Genomics; 2020; 2020():8347639. PubMed ID: 32300605
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological and Clinicopathological Characteristics of OPN in Cervical Cancers.
    Qin S; Yi L; Liang Y; Chen Y; Wang W; Liao Y; Zhang C; Huang H; Huang J; Yao S
    Front Genet; 2022; 13():836509. PubMed ID: 35669197
    [No Abstract]   [Full Text] [Related]  

  • 5. Bioinformatics analysis of differentially expressed genes and pathways in the development of cervical cancer.
    Wu B; Xi S
    BMC Cancer; 2021 Jun; 21(1):733. PubMed ID: 34174849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT1 expression and HPV16 viral load predict cervical lesion progression.
    Wu S; Wu Y; Lu Y; Yue Y; Cui C; Yu M; Wang S; Liu M; Zhao Y; Sun Z
    Oncol Lett; 2020 Oct; 20(4):28. PubMed ID: 32774501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of peripheral blood transcriptomic biomarkers to distinguish high-grade cervical squamous intraepithelial lesions from low-grade lesions.
    Zou C; Lyu Y; Jiang J; Cao Y; Wang M; Sang C; Zhang R; Li H; Liew CC; Cheng C; Zhao S
    Oncol Lett; 2020 Sep; 20(3):2280-2290. PubMed ID: 32765790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional variant at miRNA-122 binding site in IL-1a 3' UTR predicts risk of recurrence in patients with oropharyngeal cancer.
    Wang C; Sturgis EM; Chen X; Wei Q; Li G
    Oncotarget; 2016 Jun; 7(23):34472-9. PubMed ID: 27121322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis.
    Peng J; Qi S; Wang P; Li W; Liu C; Li F
    Dis Markers; 2016; 2016():6594016. PubMed ID: 27069297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional variant at miRNA-122 binding site in IL-1α 3' UTR predicts risk and HPV-positive tumours of oropharyngeal cancer.
    Zhang Y; Sturgis EM; Sun Y; Sun C; Wei Q; Huang Z; Li G
    Eur J Cancer; 2015 Jul; 51(11):1415-23. PubMed ID: 25981582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease.
    Peprah E; Xu H; Tekola-Ayele F; Royal CD
    Public Health Genomics; 2015; 18(1):40-51. PubMed ID: 25427668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives.
    Li Y; Tong Y; Wong YH
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Feb; 388(2):243-56. PubMed ID: 25413836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer progression modeling using static sample data.
    Sun Y; Yao J; Nowak NJ; Goodison S
    Genome Biol; 2014 Aug; 15(8):440. PubMed ID: 25155694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging biological treatments for uterine cervical carcinoma.
    Vici P; Mariani L; Pizzuti L; Sergi D; Di Lauro L; Vizza E; Tomao F; Tomao S; Mancini E; Vincenzoni C; Barba M; Maugeri-Saccà M; Giovinazzo G; Venuti A
    J Cancer; 2014; 5(2):86-97. PubMed ID: 24494026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulation of the miRNAs expression in cervical cancer: human papillomavirus implications.
    Gómez-Gómez Y; Organista-Nava J; Gariglio P
    Biomed Res Int; 2013; 2013():407052. PubMed ID: 24490161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.
    Li G; van Niekerk D; Miller D; Ehlen T; Garnis C; Follen M; Guillaud M; Macaulay C
    Exp Mol Pathol; 2014 Apr; 96(2):168-77. PubMed ID: 24412268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profile regulated by the HPV16 E7 oncoprotein and estradiol in cervical tissue.
    Cortés-Malagón EM; Bonilla-Delgado J; Díaz-Chávez J; Hidalgo-Miranda A; Romero-Cordoba S; Uren A; Celik H; McCormick M; Munguía-Moreno JA; Ibarra-Sierra E; Escobar-Herrera J; Lambert PF; Mendoza-Villanueva D; Bermudez-Cruz RM; Gariglio P
    Virology; 2013 Dec; 447(1-2):155-65. PubMed ID: 24210110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel function of STAT1 in breast cancer.
    Zhang M
    Oncoimmunology; 2013 Aug; 2(8):e25125. PubMed ID: 24167758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic stem cell-specific signature in cervical cancer.
    Organista-Nava J; Gómez-Gómez Y; Gariglio P
    Tumour Biol; 2014 Mar; 35(3):1727-38. PubMed ID: 24163107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor STAT1 transcription factor activity enhances breast tumor growth and immune suppression mediated by myeloid-derived suppressor cells.
    Hix LM; Karavitis J; Khan MW; Shi YH; Khazaie K; Zhang M
    J Biol Chem; 2013 Apr; 288(17):11676-88. PubMed ID: 23486482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.